ArticlePDF Available

Effectiveness of arthroscopic elbow synovectomy in rheumatoid arthritis patients: Long-term follow-up of clinical and functional outcomes

Authors:

Abstract and Figures

Objective: To determine the long-term clinical and functional results of arthroscopic elbow synovectomy in rheumatoid arthritis patients with refractory elbow synovitis in terms of improvement in pain, function, and active range of motion (AROM) or arc of motion. Method: Fifteen rheumatoid elbows in 13 patients, not responding to DMARD therapy and with radiological changes not more than Larsen grade 3 were taken, who underwent arthroscopic elbow synovectomy. The main outcome measured in forms of Mayo Elbow Performance Scale (MEPS) score, measurement of pain using a Visual Analogue Scale (VAS), radiological angles of elbow, disease activity score (DAS-28), arc of motions (AOM) and complications, which were assessed at follow-up periods of 6 months, 24 months, and 30 months. Statistical analysis was done both qualitatively and quantitatively. Mann-Whitney U test, chi-square test, and Student t test were used as the statistical test for determining significance. Results: In the study group, the improvement was sustained and significant as compared to baseline (VAS 1.28, MEPS 81.07 and mean flexion range 85°) (p value <0.001). No significant complications were encountered postoperatively after elbow synovectomy. Conclusion: The study assesses the long-term results of arthroscopic synovectomy in elbow synovitis secondary to rheumatoid arthritis with significant results favoring arthroscopic synovectomy.
Content may be subject to copyright.
Original
article
Effectiveness
of
arthroscopic
elbow
synovectomy
in
rheumatoid
arthritis
patients:
Long-term
follow-up
of
clinical
and
functional
outcomes
Vivek
Shankar
a
,
Pankaj
Sharma
b,
*,
Ravi
Mittal
b
,
Samarth
Mittal
b
,
Uma
Kumar
c
,
Shivanand
Gamanagatti
d
a
Department
of
Orthopaedics,
Sports
Injury
Centre,
New
Delhi,
India
b
Department
of
Orthopaedics,
All
India
Institute
of
Medical
Sciences,
Ansari
Nagar,
New
Delhi
110029,
India
c
Department
of
Rheumatology,
All
India
Institute
of
Medical
Sciences,
Ansari
Nagar,
New
Delhi
110029,
India
d
Department
of
Radiodiagnosis,
All
India
Institute
of
Medical
Sciences,
Ansari
Nagar,
New
Delhi
110029,
India
1.
Introduction
Rheumatoid
arthritis
(RA)
is
a
chronic
inflammatory
condition,
autoimmune
in
nature,
involving
multiple
joints
usually
present-
ing
with
pain,
swelling,
inflammation,
stiffness,
and
possible
loss
of
functions
at
joints.
1,2
The
pattern
of
joint
involvement
varies,
wrist
being
the
most
frequently
involved
joint
(87%),
whereas
shoulder,
knees,
ankle,
and
elbow
are
involved
in
47%,
56%,
53%,
21%
respectively
at
the
time
of
presentation.
3
Rheumatoid
arthritis
is
the
most
common
cause
of
elbow
arthritis.
Involvement
of
elbow
joint
in
rheumatoid
arthritis
occurs
in
20–25%
within
5
years,
and
about
66%
will
show
definitive
involvement
within
15
years
of
disease
onset.
4,5
Incidence
of
disease
is
variable
in
different
regions
but
generally
increases
between
25
and
55
years
of
age,
remain
stable
or
in
a
static
manner
up
to
the
age
of
75
years
and
then
decreases.
1,2
Drugs
commonly
used
for
treatment
are
NSAIDs,
DMARDs,
Steroids,
and
new
biological
modifier
drugs
including
anti-TNF
drugs.
Due
to
their
high
cost,
non-availability,
poor
motivation
for
drugs
schedule,
and
observation
of
outcome
in
Indian
population,
these
drugs
are
not
widely
used.
There
are
poor
immunity
status
and
unhygienic
conditions
in
Indian
localities,
which
may
lead
to
accentuation
of
active
and
latent
infective
complications
and
respiratory
problems.
There
are
several
diseases
in
India
like
high
prevalence
of
tuberculosis,
which
may
be
aggravated,
or
their
progression
and
pathogenesis
altered
with
Journal
of
Clinical
Orthopaedics
and
Trauma
7S
(2016)
230–235
A
R
T
I
C
L
E
I
N
F
O
Article
history:
Received
2
April
2016
Received
in
revised
form
20
May
2016
Accepted
30
May
2016
Available
online
23
June
2016
Keywords:
Arthroscopic
synovectomy
Visual
Analogue
Scale
(VAS)
score
Mayo
Elbow
Performance
Scale
(MEPS)
Arc
of
motion
(AOM)
Disease
activity
score
(DAS-28)
Larsen
grading
A
B
S
T
R
A
C
T
Objective:
To
determine
the
long-term
clinical
and
functional
results
of
arthroscopic
elbow
synovectomy
in
rheumatoid
arthritis
patients
with
refractory
elbow
synovitis
in
terms
of
improvement
in
pain,
function,
and
active
range
of
motion
(AROM)
or
arc
of
motion.
Method:
Fifteen
rheumatoid
elbows
in
13
patients,
not
responding
to
DMARD
therapy
and
with
radiological
changes
not
more
than
Larsen
grade
3
were
taken,
who
underwent
arthroscopic
elbow
synovectomy.
The
main
outcome
measured
in
forms
of
Mayo
Elbow
Performance
Scale
(MEPS)
score,
measurement
of
pain
using
a
Visual
Analogue
Scale
(VAS),
radiological
angles
of
elbow,
disease
activity
score
(DAS-28),
arc
of
motions
(AOM)
and
complications,
which
were
assessed
at
follow-up
periods
of
6
months,
24
months,
and
30
months.
Statistical
analysis
was
done
both
qualitatively
and
quantitatively.
Mann–Whitney
U
test,
chi-square
test,
and
Student
t
test
were
used
as
the
statistical
test
for
determining
significance.
Results:
In
the
study
group,
the
improvement
was
sustained
and
significant
as
compared
to
baseline
(VAS
1.28,
MEPS
81.07
and
mean
flexion
range
858)
(p
value
<0.001).
No
significant
complications
were
encountered
postoperatively
after
elbow
synovectomy.
Conclusion:
The
study
assesses
the
long-term
results
of
arthroscopic
synovectomy
in
elbow
synovitis
secondary
to
rheumatoid
arthritis
with
significant
results
favoring
arthroscopic
synovectomy.
ß
2016
Delhi
Orthopedic
Association.
All
rights
reserved.
*Corresponding
author
at:
Room
no
206,
F.T.A.
Flats,
A.V.
Nagar,
New
Delhi
110049,
India.
Tel.:
+91
9013590572.
E-mail
addresses:
drshankarvivek@gmail.com
(V.
Shankar),
dr.pankajkristwal@gmail.com
(P.
Sharma),
ravimittal66@hotmail.com
(R.
Mittal),
samarthmittal@gmail.com
(S.
Mittal),
Umaakumar@yahoo.com
(U.
Kumar),
shiv223@gmail.com
(S.
Gamanagatti).
Contents
lists
available
at
ScienceDirect
Journal
of
Clinical
Orthopaedics
and
Trauma
jou
r
nal
h
o
mep
ag
e:
w
ww
.elsevier
.co
m
/loc
ate/jc
o
t
http://dx.doi.org/10.1016/j.jcot.2016.05.011
0976-5662/ß
2016
Delhi
Orthopedic
Association.
All
rights
reserved.
changing
immune
status
by
mentioned
drugs.
6
Open
or
arthro-
scopic
synovectomy
may
be
useful
in
some
patients
with
persistent
mono-arthritis
(mild
to
moderate),
particularly
when
refractory
to
conservative
management.
As
synovium
primarily
plays
an
important
role
in
the
pathogenesis
and
disease
progres-
sion,
synovectomy
or
removal
of
inflamed
synovial
membrane
is
the
corner
stone
in
the
management
of
joint
inflammation
refractory
to
optimal
DMARD
therapy.
Arthroscopies
are
being
done
with
increasing
frequency
to
diagnose
and
treat
elbow
disorders
and
arthroscopic
synovectomy
of
elbow
joint
can
be
used
successfully
to
provide
pain
relief.
6–9
Unfortunately,
there
are
very
few
studies
dealing
with
the
effectiveness
of
elbow
arthroscopic
synovectomy
in
rheumatoid
arthritis
and
there
are
none
from
the
Indian
sub-continent.
The
present
study
was
undertaken
to
evaluate
the
effectiveness
of
arthroscopic
synovectomy
in
rheumatoid
arthritis
involving
elbow
joint.
2.
Material
and
methods
Fifteen
diagnosed
cases
of
rheumatoid
elbow
based
on
‘‘The
American
College
of
Rheumatology
1987
Revised
Criteria’’
for
the
diagnosis
of
rheumatoid
arthritis
not
responsive
to
optimal
DMARD
therapy
and
radiological
changes
not
more
than
Larsen
grade
3
were
selected.
Exclusion
criteria
included
history
of
trauma
to
the
affected
joint,
patient
with
history
of
septic
arthritis
of
elbow
joint,
gross
deformity
of
the
elbow,
and
severe
radiological
destruction
of
the
joint
with
Larsen
grade
4
or
more.
All
the
patients
continued
to
have
DMARD
therapy.
3.
Operative
method
All
the
patients
were
given
general
anesthesia
and
placed
in
prone
position
with
high
tourniquet
in
the
upper
arm.
The
arm
was
abducted
to
908
and
elbow
flexed
to
908
with
keeping
forearm
hanging
free.
The
bony
anatomical
landmarks
viz.,
the
radial
head,
the
olecranon,
and
the
lateral
and
medial
humeral
epicondyles
were
outlined
with
a
marking
pen.
Ulnar
nerve
was
also
palpated
and
marked.
20
ml
of
sterile
normal
saline
was
injected
into
the
elbow
joint
through
the
soft
spot,
to
distend
it.
Anteromedial,
anterolateral,
midlateral,
posterocentral,
and
posterolateral
por-
tals
were
used
for
surgery
to
get
a
maximum
view
of
the
joint
and
to
remove
the
synovium
with
help
of
4
mm
shaver
tip.
Posteromedial
portal
was
omitted
for
arthroscopy
to
avoid
ulnar
nerve
injury
in
such
a
stiff
joint.
Anteromedial
portal
(proximal
medial
portal)
is
the
primary
viewing
portal
for
arthroscopy
of
the
elbow
in
the
prone
position,
located
approx.
one
finger
breadth
proximal
to
the
medial
epicondyle
and
1–2
cm
anterior
to
the
intermuscular
septum.
With
the
joint
distended,
median
nerve
lies
approximately
2
cm,
and
the
brachial
artery
2.2
cm
from
the
portal.
The
ulnar
nerve
is
protected
by
keeping
the
trocar
anterior
to
the
intermuscular
septum.
Anterolateral
portal
(proximal
lateral
portal)
is
located
2
cm
proximal
to
the
lateral
epicondyle
and
1
cm
anterior
to
the
inter-muscular
septum.
It
is
approximately
4.8
mm
away
from
the
radial
nerve
with
the
elbow
in
extension
and
approximately
9.9
mm
away
with
the
elbow
in
flexion.
Midlateral
portal
(soft
spot
portal)
is
located
in
the
center
of
the
triangle
formed
by
the
radial
head,
the
lateral
epicondyle
of
the
humerus,
and
the
tip
of
the
olecranon.
It
is
the
portal
most
often
used
for
the
distension
of
the
joint.
Posterocentral
(straight
posterior)
portal
is
located
in
the
midline,
approximately
3
cm
proximal
to
the
tip
of
the
olecranon.
It
enters
directly
through
the
triceps
tendon
and
is
therefore
safe.
The
midlateral
and
posterocentral
(straight
posterior)
portals
can
be
used
alternately
as
diagnostic
and
operative
portals.
Posterolateral
portal
lies
just
lateral
to
the
posterior
portal,
i.e.,
3
cm
proximal
to
olecranon
tip
just
lateral
to
the
midline.
All
the
synovium
from
medial,
lateral
and
posterior
compartments
was
removed.
No
attempt
was
made
to
view
the
posteromedial
compartment
in
order
to
avoid
any
risk
to
the
ulnar
nerve.
Radial
head
excision
was
not
done
in
any
patient
but
clearing
of
soft
tissue
and
loose
bodies
from
olecranon
fossa
took
place.
The
joint
was
washed
thoroughly
with
three
liters
of
normal
saline
and
portals
were
closed
with
2.0
nylon
sutures.
Antiseptic
dressing
was
applied
and
compression
bandages
were
given.
Cefotaxime
coverage
was
continued
for
two
days
and
stopped.
Oral
analgesics
were
given
for
seven
days
postoperatively.
Elbow
mobilization
and
physiotherapy
were
started
from
the
second
post-operative
day.
3.1.
Evaluation
and
biostatics
analysis
We
studied
and
followed
the
following
parameters
in
our
study.
5–11
-
Visual
analogue
score
for
pain
-
Mayo
elbow
performance
score
including
100
maximum
points
(pain,
max.
45),
(motions,
max.
20),
(daily
function,
max.
25)
and
(stability,
max.
10
points)
-
Arc
of
flexion
-
Coronoid
height
ratio
-
Modified
Larsen
grade
-
Disease
activity
score-28
(DAS-28)
These
parameters
were
recorded
before
the
intervention
and
at
6
months,
24
months,
and
30
months
after
intervention.
The
statistical
analysis
would
be
carried
out
by
using
SPSS
version
15
for
qualitative
data.
The
analytical
technique
used
would
be
chi
square
test
or
Fisher
test
wherever
necessary.
For
quantitative
data,
Student
t-test
or
Mann–Whitney
test
would
be
done.
The
changeover
period
of
time
in
VAS
score
and
CoHR
would
be
analyzed
by
applying
repeated
measure
analysis
followed
by
post-
hoc
test.
The
p
value
of
<0.05
would
be
considered
as
significant.
Clinical
and
radiological
follow-up
of
two
patients
are
illustrated
in
Figs.
1
and
2
(clinical
and
radiological
photographs
of
a
patient
at
pre-op
and
different
follow-up
periods).
4.
Observation
and
results
Patient
profile
and
parameters
at
the
commencement
of
study
are
listed
in
Table
1.
In
this
study,
the
patient’s
age
ranged
from
26
to
62
years,
the
mean
age
being
41.7
9.7
years.
Male:female
ratio
was
1:12.
All
the
parameters
included
and
observed
in
study
are
summarized
in
Table
2.
There
was
significant
improvement
in
VAS
after
arthroscopic
procedure
when
compared
to
pre-operative
status
at
the
end
of
6
months,
24
months,
and
30
months
observation.
One
patient
had
exacerbation
of
pain
and
one
of
them
experienced
similar
pain
as
pre-operative
status
Table
1
Parameters
and
characteristics
of
patients
at
the
start
of
study.
Parameters
Mean
S.D.
Age
(years)
41.7
9.7
Duration
of
disease
(months)
94
74.5
Duration
of
right
elbow
involvement
(months)
59.2
80
Duration
of
left
elbow
involvement
(months)
54
79
E.S.R.
(mm/1
h)
58.5
16.6
Duration
of
NSAID
intake
(months)
101.6
72.1
Duration
of
DMARD
intake
(months)
51.7
64.3
Pre-op
visual
analogue
score
6.4
1.7
Pre-op
Mayo
elbow
performance
score
53.3
17
Pre-op
arc
of
flexion
67.66
27.70
Pre-op
modified
Larsen
score
2.5
0.5
Pre-op
coronoid
height
ratio
50.4
10.8
Pre-op
disease
activity
score
6.6
1.1
V.
Shankar
et
al.
/
Journal
of
Clinical
Orthopaedics
and
Trauma
7S
(2016)
230–235
231
during
this
period.
There
was
significant
improvement
in
MEPS
score
after
the
surgical
procedure
at
the
end
of
6
months,
24
months,
and
at
30
months.
All
patients
in
our
study
presented
with
improvement
in
MEPS
except
for
one
patient
where
the
score
remained
the
same.
No
patient
had
any
loss
of
function
in
this
group.
We
did
not
observe
any
significant
difference
in
the
mean
CoHR
and
modified
Larsen
scores
between
pre-operative
and
post-operative
values
in
group.
In
our
study,
we
observed
significant
results
when
Fig.
2.
Clinical
and
radiological
photographs
of
a
patient
at
pre-op
and
different
follow-up
periods.
Fig.
1.
Clinical
and
radiological
photographs
of
a
patient
at
pre-op
and
different
follow-up
periods.
V.
Shankar
et
al.
/
Journal
of
Clinical
Orthopaedics
and
Trauma
7S
(2016)
230–235
232
compared
between
pre-op
arc
of
flexion
and
30-month
follow-up
and
p
value
was
found
to
be
0.026.
Our
study
being
followed
up
of
thirteen
months
was
not
of
enough
period
to
note
any
significant
radiological
changes.
Hence,
we
suggest
that
a
long-term
follow-up
may
give
better
information
on
the
above
to
parameters
with
respect
to
time.
Clinical
and
radiological
photographs
of
two
patients
are
illustrated
in
Figs.
1
and
2,
which
elaborate
changes
over
follow-up
periods.
According
to
the
EULAR
response
criteria,
there
were
no
response
over
the
time
points
in
study
group
for
6,
24,
and
30
months
follow-
up
post-operatively
as
shown
in
Table
3.
11
In
the
study,
patients
group
performed
better
at
6
months
follow-up,
but
it
was
difficult
to
conclude
whether
improvement
was
due
to
arthroscopy
or
continuation
of
DMARD.
It
is
also
difficult
to
make
any
decision
regarding
effectiveness
of
surmise
that,
how
synovectomy
of
a
single
joint
can
have
such
a
significant
generalized
improvement.
5.
Discussion
It
is
an
autoimmune
disease
where
the
body’s
immune
system
affects
joints,
soft
tissues,
and
periarticular
soft
tissues
leading
to
inflammation
and
producing
various
symptoms,
ranging
from
pain,
morning
stiffness
to
deformities
of
joints.
Management
of
patients
with
RA
involves
an
interdisciplinary
approach,
which
attempts
to
deal
with
the
various
problems
that
persist
in
systemic
manner.
Drug
treatment
includes
various
drugs,
either
single
or
in
combinations
form.
Combination
drug
therapy,
using
disease-
modifying
anti-rheumatic
drugs
and
biologic
therapies
are
very
effective,
and
complete
resolution
of
signs
and
symptoms
is
achievable
in
approximately
10%
of
patients.
Intra-articular
steroid
injection
may
relieve
joint
inflammation
and
reduce
symptoms
in
early
stages.
Surgery
plays
an
important
role
in
the
management
of
patients
with
severely
damaged
joints
by
considering
age,
functional
demands,
etiology,
and
severity
of
elbow
arthritis.
Synovectomy,
arthroplasty,
and
arthrodesis
of
elbow
have
been
practiced
since
long
with
variable
results.
Synovectomy
for
inflamed
joint
has
been
practiced
for
long
and
has
shown
good
results
for
pain
relief
in
the
past.
12
Various
studies
have
shown
to
improve
the
function
of
the
joint
following
synovectomy,
either
in
the
form
of
open
or
arthroscopic
synovectomy.
13–20
Open
synovectomy
is
quiet
easier
and
less
demanding
technically
than
arthroscopic
procedure
but
there
is
less
morbidity
and
early
rehabilitation
in
arthroscopic
approach.
20
By
avoiding
neurovascular
structures
injury
with
proper
pre-operative
planning
and
intraoperative
precautions,
arthroscopic
synovectomy
can
give
better
results
in
terms
of
less
morbidity
and
early
functional
outcome.
The
mean
duration
of
disease
in
study
group
was
94
months
and
the
mean
age
of
the
patients
in
it
was
41.7
9.7
years.
Male
to
female
ratio
was
1:12.
The
mean
visual
analogue
score
(VAS)
at
the
time
of
enrolment
in
the
study
was
6.21
1.57
(dreadful
pain).
Post-
operatively,
at
6-months
follow-up,
it
was
0.42
0.5
(nearly
no
pain).
As
the
time
passed
away,
pain
increased
progressively
over
2
year
in
these
patients.
Mean
VAS
at
the
24
months
and
30
months
follow-up
were
1.14
0.84
and
1.285
1.06
(mild
pain),
respectively.
Chung
et
al.
conducted
a
study
in
13
elbow
joints
for
mean
34-months
(range
18–78)
follow-up.
21
The
mean
VAS
pain
score
decreased
significantly
from
nine
(range
5–10)
preoperatively
to
four
(range
2–6)
at
one
week
and
to
one
(range
0–7)
at
the
final
follow-up
of
34
months.
The
results
were
significant
with
p
value
of
0.005
and
0.004,
respectively.
These
were
similar
to
our
results.
Kang
performed
arthroscopic
synovectomy
and
studied
mean
follow-up
of
33.9
months
on
26
rheumatoid
elbows
in
25
patients.
22
The
mean
VAS
for
pain
decreased
from
6.5
points
(range
5.1–9.2)
preoperatively
to
3.1
points
(range
1.5–8.2
points)
at
the
final
follow-up,
showing
significantly
less
pain
post-operatively
with
p
value
of
0.001.
Our
final
VAS
for
pain
score
was
1.285
1.06,
much
lower
than
this
study.
These
changes
over
the
time
are
illustrated
in
graph
(Fig.
3).
The
mean
modified
Larsen
grade
at
the
time
of
commencement
of
the
study
was
2.428
0.5
(range
2–3),
and
remained
same
at
6-
months
follow-up.
The
mean
values
for
score
were
2.50
0.65
(range
2–4)
at
24-months
and
30-months
follow-up.
Kang
et
al.
started
a
study
of
26
patients,
in
which
ten
included
in
grade
1,
thirteen
in
grade
2,
and
three
patients
in
grade
3.
22
At
final
follow-up,
10
elbows
were
classified
as
grade
1,
10
as
grade
2,
4
as
grade
3,
and
2
as
grade
4.
After
33.9-months
follow-up,
there
was
a
reduction
in
degenerative
change
by
one
grade
in
6
elbows,
progression
by
grade
in
7
elbows
and
no
change
in
thirteen
elbows.
Chung
et
al.
mentioned
Modified
Larsen
Grading
for
radiological
assessment
in
pre-operative
period,
but
did
not
evaluate
same
parameter
in
post-operative
follow-up.
21
Horiuchi
et
al.
followed
21
patients,
who
underwent
arthroscopic
synovectomy
with
observation
for
a
mean
period
of
97
months.
20
Larsen
grade
increased
in
17
out
of
21
elbows
even
after
surgery.
We
did
not
find
any
significant
changes
in
modified
Larsen
grading.
A
Table
3
Change
in
disease
activity
score
(DAS-28)
improvement
over
time
points
(6,
24,
30
months)
post-operatively.
DAS-28
(>5.1)
0–6
months
0–24
months
0–30
months
0.78
0.62
0.51
No
response
No
response
No
response
Table
2
Patients
parameters
at
pre-intervention
and
follow-up
periods
of
6,
24
and
30
months.
Parameters
(mean
S.D.)
0
month
6
months
follow-up
24
months
follow-up
30
months
follow-up
p
value
(0
and
6
months)
p
value
(0
and
24
months)
p
value
(0
and
30
months)
VAS
6.21
1.5
0.42
0.5
1.14
0.5
1.28
0.5
0.001
0.001
0.001
MEPS
54.28
17.19
91.07
10.4
82.5
15.28
81.07
15.08
0.001
0.001
0.001
Arc
of
flexion
68.9
28.29
94.2
23.44
85.0
21.03
85.0
21.03
0.003
0.026
0.026
Modified
Larsen
score
2.42
0.5
2.42
0.5
2.5
0.65
2.5
0.65
1.0
0.336
0.336
CoHR
49.5
10.63
49.85
10.21
50.92
10.9
51.14
10.78
0.81
0.24
0.17
DAS-28
6.48
1.01
5.7
1.04
5.86
1.09
5.97
1.09
0.001
0.005
0.005
Fig.
3.
VAS
score
for
pain
in
arthroscopy
group
patients.
V.
Shankar
et
al.
/
Journal
of
Clinical
Orthopaedics
and
Trauma
7S
(2016)
230–235
233
long-term
follow-up
of
97
months
may
be
a
cause
of
such
deterioration
in
above
study
in
comparison
to
our
study.
These
changes
over
the
time
are
illustrated
in
graph
(Fig.
4).
The
mean
coronoid
height
ratio
(CoHR)
at
the
time
of
commencement
of
our
study
was
49.5
10.63
(range
33–70)
and
49.85
10.2
(range
30–70)
at
6-months
follow-up.
It
changed
over
time
at
the
24-
and
30-months
follow-up,
50.928
10.91
and
51.142
10.75,
respectively.
Nemoto
et
al.
conducted
a
study
and
evaluated
the
results
of
arthroscopic
synovectomy
of
eleven
rheumatoid
elbows
in
10
patients
with
a
mean
follow-up
of
3
years
and
1
month.
19
The
mean
CoHR
in
group
A
preoperatively
was
54.2
7.3
and
postoperatively
was
56.3
6.8
and
was
found
not
significant.
But
in
Group
B
preoperatively
CoHR
was
62.4
6.2
and
postoperatively
was
67.4
3.1
and
it
was
found
significant
when
compared
with
p
<
0.05.
We
had
patients
only
in
Larsen
grade
2
or
3
in
our
arthroscopic
synovectomy
group.
We
did
not
observe
any
significant
difference
in
the
mean
CoHR
between
pre-operative
and
post-operative
group
similar
to
their
study
at
the
end
of
our
follow-
up.
As
there
were
no
patients
operated
with
a
pre-operative
Larsen
grade
4,
a
correlation
is
not
possible
with
group
B.
These
changes
over
the
time
are
illustrated
in
graph
(Fig.
5).
The
mean
disease
activity
score
(DAS-28)
at
the
time
of
commencement
of
our
study
was
6.48
1.01
(range
4.9–7.9)
and
5.70
1.04
(range
4.3–7.9)
at
6-months
follow-up,
which
changed
at
24
months
as
5.86
1.095
and
at
30
months,
to
5.97
1.094
(range
4.4–7.68)
in
patients.
There
are
no
studies
in
literature,
which
show
correlation
between
arthroscopy
and
DAS-28.
The
mean
arc
of
flexion
at
the
time
of
commencement
was
68.92
28.29
(range
20–1308)
and
94.28
23.44
(range
30–130)
at
6-months
follow-up,
which
further
decreased
in
mean
values
around
85
21.031
(range
30–120)
at
final
follow-up
of
30
months.
In
Kang
et
al.,
study,
the
mean
flexion-extension
arc
improved
from
98.18
preoperatively
to
113.38
post-operatively.
22
The
results
were
signifi-
cant
with
p
value
of
0.032.
The
mean
rotation
arc
increased
insignificantly
from
146.38
to
159.58
post-operatively,
with
p
value
of
0.75.
In
our
study,
we
observed
significant
results
when
compared
between
pre-op
arc
of
flexion
and
30-months
follow-up
and
p
value
was
found
to
be
0.026.
Results
were
similar
to
this
study
and
show
the
effectiveness
of
arthroscopic
synovectomy
in
rheumatoid
elbow.
Chung
et
al.
in
their
study
of
arthroscopic
synovectomy
of
26
elbows
observed
for
34
months.
21
The
median
elbow
flexion-extension
arc
improved
significantly
from
758
to
1058,
with
p
value
of
0.004.
Result
was
similar
to
that
of
our
study.
Lee
and
Morrey,
evaluated
fourteen
arthroscopic
synovectomies
with
mean
arc
of
flexion
preoperatively
91
(range
45–1308)
and
the
mean
in
post-operative
period
108
(range
75–1208),
showing
an
improvement
of
178.
23
We
reported
16.088
improvement
in
our
study.
These
changes
over
the
time
are
illustrated
in
graph
(Fig.
6).
Pre-operative
mean
value
of
MEPS
was
54.28
17.19
(signifying
poor
elbow
performance
score)
in
the
group.
At
6-months
follow-up,
it
was
91.07
10.77
with
excellent
elbow
performance
score,
while
at
the
24
and
30
months,
the
mean
values
were
82.5
15.28
and
81.07
15.086,
respectively.
We
observed
good
results
in
all
patients
except
one
where
the
score
deteriorated
over
the
time
of
24
months
and
30
months.
We
also
noticed
no
failure
during
our
6-months
follow-up.
Kang
et
al.,
in
their
study
of
26
patients,
observed
improvement
in
mean
Mayo
elbow
performance
score
from
58.5
points
preoperatively
to
77.4
points
at
the
final
follow-up
with
the
p
value
of
0.02.
22
Inglis
et
al.,
in
their
study
of
28
patients,
graded
result
as
good,
satisfactory,
and
poor
without
using
of
MEPS.
13
They
reported
50%
good
results
(14
out
of
28
patients).
6
patients
had
satisfactory
results,
while
4
as
failures,
with
3
ankylosed
joints
and
1
recurrent
synovitis.
Tanaka
et
al.,
conducted
a
study
of
58
arthro-
scopic
synovectomy
and
53
open
synovectomy
with
a
follow-up
of
13
years
and
3–5
years
mid-term
follow-up.
18
Mean
MEPS
in
both
the
groups
were
50
preoperatively.
There
was
a
similar
improvement
in
MEPS
in
both
the
group
at
3–5
year
follow-up
with
MEPS
78
but
noted
a
difference
at
13
year
follow
up
with
MEPS
in
arthroscopy
group
67
and
open
synovectomy
group
71
and
concluded
that
there
is
a
significant
improvement
in
MEPS
in
both
arthroscopy
and
open
synovectomy
at
short-term
and
long-term
follow-up
but
the
gain
in
improvement
tends
to
decrease
more
in
arthroscopy
group
than
in
open
synovectomy
group.
Our
study
has
a
better
gain
in
the
MEPS
(81.07
15.086)
at
the
30-months
follow-up
but
the
results
are
formalized
in
30-months
follow-up
as
compared
to
13-years
follow-
up
in
the
above
study.
Lee
and
Morrey,
performed
arthroscopic
synovectomy
on
14
elbows
and
reported
post-operative
MEPS
as
78
(signifying
good
elbow
performance
score).
23
He
concluded
that
arthroscopic
synovectomy
has
a
good
short-term
success
but
tends
to
deteriorate
with
time.
Similar
results
were
found
in
Horiuchi
et
al.
study,
where
they
performed
arthroscopic
synovectomy
in
Fig.
6.
Arc
of
flexion
in
arthroscopy
group
patients.
Fig.
4.
Modified
Larsen
score
in
arthroscopy
group
patients.
Fig.
5.
Coronoid
height
ratio
(CoHR)
in
arthroscopy
group
patients.
V.
Shankar
et
al.
/
Journal
of
Clinical
Orthopaedics
and
Trauma
7S
(2016)
230–235
234
21
patients.
20
Mean
MEPS
at
2-years
follow-up
was
77.5
while
at
11-
years
follow-up,
it
was
69.8.
We
noticed
in
all
previous
studies
that
MEPS
had
improved
significantly
but
there
is
a
trend
to
deteriorate
with
passage
of
time.
In
a
similar
way,
our
study
has
excellent
result
at
6
months
but
deteriorate
progressively
at
the
24-months
and
30-
months
follow-up.
These
changes
over
the
time
are
illustrated
in
graph
(Fig.
7).
6.
Limitations
The
sample
size
was
small
and
the
follow-up
was
only
for
two
and
an
half
years.
A
longer
follow-up
can
reveal
a
different
pattern
of
disease
status,
particularly
radio-graphically.
DMARDs
and
other
drugs
prescribed
by
rheumatologist
were
different
in
different
patient
according
to
their
clinical
picture.
This
confound-
ing
factor
was
not
included
in
the
study.
7.
Conclusions
We
concluded
in
our
study
that
Pain
and
decreased
range
of
movements
of
joints
were
the
most
important
indications
for
any
intervention
in
patients
of
rheumatoid
arthritis.
Short-term
(at
6
months)
pain
relief
after
arthroscopic
synovectomy
was
excellent.
Long-term
(at
30
months)
pain
relief
is
better
achieved
with
arthroscopic
synovectomy
along
with
DMARD.
Arthroscopic
synovectomy
produces
satisfactory
improvement
in
elbow
func-
tions
in
form
of
range
of
moments
and
MEPS
parameters,
both
in
short-term
and
long-term
follow-up.
Little
deterioration
over
the
time
was
observed
in
all
the
mentioned
parameters.
Significant
changes
in
radiological
grade
are
not
notable
in
short-term
(6
month)
and
long-term
(30
months)
follow-up.
There
is
no
response,
according
to
new
EULAR
classification
criteria
in
short-
term
as
well
as
in
long-term
follow-up
study
for
DAS-28
scoring.
Therefore,
arthroscopic
synovectomy
considered
as
an
effective
intervention,
as
a
surgical
management
of
rheumatoid
elbow,
refractory
to
conservative
treatment.
Ethical
statement
The
study
was
started
after
obtaining
ethical
approval
from
members
of
ethics
committee
of
institute
with
reference
number
IESC/T-207/06.05.2011.
Informed
consent
Informed
written
consent
was
obtained
from
patients
and
their
attendants.
Financial
support
No
author
had
any
financial
support
for
study
and
article.
Conflicts
of
interest
The
authors
have
none
to
declare.
Acknowledgement
We
are
thankful
to
all
patients
and
persons,
who
are
actively
involved
in
this
study.
References
1.
Elipsky
P.
Rheumatoid
arthritis.In:
Harrison’s
Principles
of
Internal
Medicine.
17th
ed.
New
York:
The
McGraw-Hill
Companies;
2008:2083–2092.
2.
Shah
A,
Clair
EW.
Rheumatoid
arthritis.In:
Harrison’s
Principles
of
Internal
Medicine.
19th
ed.
New
York:
The
McGraw-Hill
Companies;
2012:2136–2149.
3.
Edward
JH,
ed.
In:
Clinical
features
of
Rheumatoid
Arthritis.
1994.
4.
Ellison
MR,
Kelly
KJ,
Flatt
AE.
The
results
of
surgical
synovectomy
of
the
digital
joints
in
rheumatoid
disease.
J
Bone
Joint
Surg
Am.
1971;53:1041–1060.
5.
Scott
DL,
Symmons
DP,
Coulton
BL,
Popert
AJ.
Long-term
outcome
of
treating
rheumatoid
arthritis:
results
after
20
years.
Lancet.
1987;16:1108–1111.
6.
Shankar
S,
Handa
R.
Biological
agents
in
rheumatoid
arthritis.
J
Postgrad
Med.
2004;50:293–299.
7.
Morrey
BF,
An
KN,
Chao
EYS.
Functional
evaluation
of
the
elbow.
In:
Morrey
BF,
ed.
In:
In:
The
Elbow
and
Its
Disorders
2nd
ed.
W.
B.
Saunders;
1993.
8.
Larsen
A,
Dale
K,
Eek
M.
Radiographic
evaluation
of
rheumatoid
arthritis
and
related
conditions
by
standard
reference
films.
Acta
Radiol
Diagn.
1977;18:
481–491.
9.
Ando
T,
Namiki
O,
Inagaki
K,
Hirahara
H,
Fujimaki
E.
Natural
history
of
the
elbow
joint
in
rheumatoid
arthritis.
J
Showa
Med
Assoc.
2000;60:399–406.
10.
Prevoo
ML,
van’t
Hof
MA,
Kuper
HH,
van
Leeuwen
MA,
van
de
Putte
LB,
van
Riel
PL.
Modified
disease
activity
scores
that
include
twenty-eight-joint
counts.
Develop-
ment
and
validation
in
a
prospective
longitudinal
study
of
patients
with
rheuma-
toid
arthritis.
Arthritis
Rheum.
1995;38:44–48.
11.
Fransen
J,
van
Riel
PLCM.
The
Disease
Activity
Score
and
the
EULAR
response
criteria.
Clin
Exp
Rheumatol.
2005;23:S93–S9951.
12.
Lopes
RV,
Furtado
RNV,
Parmigiani
L,
Rosenfeld
A,
Fernandes
ARC,
Natour
J.
Accuracy
of
intra-articular
injections
in
peripheral
joints
performed
blindly
in
patients
with
rheumatoid
arthritis.
Rheumatology.
2008;47:1792–1794.
13.
Inglis
AE,
Ranawat
CS,
Straub
LR.
Synovectomy
and
debridement
of
the
elbow
in
rheumatoid
arthritis.
J
Bone
Joint
Surg
Am.
1971;53:652–662.
14.
Maenpaa
H,
Kuusela
P,
Lehtinen
J,
Savolainen
A,
Kautiainen
H,
Belt
E.
Elbow
synovectomy
on
patients
with
juvenile
rheumatoid
arthritis.
Clin
Orthop
Relat
Res.
2003;412:65–70.
15.
Maenpaa
HM,
Kuusela
PP,
Kaarela
K,
Kautiainen
HJ,
Lehtinen
JT,
Belt
EA.
Reopera-
tion
rate
after
elbow
synovectomy
in
rheumatoid
arthritis.
J
Shoulder
Elbow
Surg.
2003;12:4803.
16.
Copeland
SA,
Taylor
JG.
Synovectomy
of
the
elbow
in
rheumatoid
arthritis:
the
place
of
excision
of
the
head
of
the
radius.
J
Bone
Joint
Surg
Br.
1979;61:69–73.
17.
Ferlic
DC,
Patchett
CE,
Clayton
ML,
Freeman
AC.
Elbow
synovectomy
in
rheumatoid
arthritis.
Long-term
results.
Clin
Orthop
Relat
Res.
1987;220:119–125.
18.
Tanaka
N,
Sakahashi
H,
Hirose
K,
Ishima
T,
Ishii
S.
Arthroscopic
and
open
synovectomy
of
the
elbow
in
rheumatoid
arthritis.
J
Bone
Joint
Surg
Am.
2006;88:521–525.
19.
Nemoto
K,
Arino
H,
Yoshihara
Y,
Fujikawa
K.
Arthroscopic
synovectomy
for
the
rheumatoid
elbow:
a
short-term
outcome.
J
Shoulder
Elbow
Surg.
2004;13:
652–655.
20.
Horiuchi
K,
Momohara
S,
Tomatsu
T,
Inoue
K,
Toyama
Y.
Arthroscopic
synovectomy
of
the
elbow
in
rheumatoid
arthritis.
J
Bone
Joint
Surg
Am.
2002;84-A:342–347.
21.
Chung
CYS,
Yen
CH,
Yip
MLR,
Koo
SCJJ,
Lao
WN.
Arthroscopic
synovectomy
for
rheumatoid
wrists
and
elbows.
J
Orthop
Surg.
2012;20:219–223.
22.
Kang
HJ,
Park
MJ,
Ahn
JH,
Lee
SH.
Arthroscopic
synovectomy
for
the
rheumatoid
elbow.
Arthroscopy.
2010;26:1195–1202.
23.
Lee
BP,
Morrey
BF.
Arthroscopic
synovectomy
of
the
elbow
for
rheumatoid
arthritis.
A
prospective
study.
J
Bone
Joint
Surg
Br.
1997;79:770–772.
Fig.
7.
Mayo
elbow
performance
score
(MEPS)
in
arthroscopy
patients.
V.
Shankar
et
al.
/
Journal
of
Clinical
Orthopaedics
and
Trauma
7S
(2016)
230–235
235
... Also, surgery cannot be performed repeatedly (Yasutaka et al., 2016). Compared with traditional surgery, arthroscopic synovectomy truly has some advantages, however, it still have some blind spots (Vivek et al., 2016). Other treatment measures such as chemical synovectomy and radio-surgical resection can reduce joint exudation and prevent cartilage protection, but they could cause damage to other normal tissues (Winkler et al., 2013). ...
Article
Full-text available
Rheumatoid Arthritis is a universal disease that severely affects the normal function of human joints and the quality of life. Millions of people around the world are diagnosed with rheumatoid arthritis every year, carrying a substantial burden for both the individual and society. Hydrogel is a polymer material with good mechanical properties and biocompatibility, which shows great potential in the treatment of rheumatoid arthritis. With the progress of tissue engineering and biomedical material technology in recent years, more and more studies focus on the application of hydrogels in rheumatoid arthritis. We reviewed the progress of hydrogels applied in rheumatoid arthritis in recent years. Also, the needed comprehensive performance and current applications of therapeutic hydrogels based on the complex pathophysiological characteristics of rheumatoid arthritis are also concluded. Additionally, we proposed the challenges and difficulties in the application of hydrogels in rheumatoid arthritis and put forward some prospects for the future research.
... Identification with additional synovitis diseases is necessary before diagnosis, including rheumatoid synovitis, gouty synovitis, infectious synovitis, pigmented villonodular synovitis, and synovial chondromatosis [10][11][12][13][14][15] . As the optimal detection of RBS, MRI findings are very typical. ...
Article
Full-text available
Background: Rice body synovitis (RBS) is a rare disease. It is prone to be developed due to rheumatoid disorder or tuberculosis infection. Additional infectious arthritis (non-tuberculous mycobacterial infection and fungal infection), juvenile arthritis, the onset of adult Still's disease, systemic lupus erythematosus (SLE), seronegative arthritis, and non-specific arthritis. The clinical imaging, histopathological features, and surgical treatment process of a patient were documented combined with literature. Furthermore, differentiation was performed with additional synovitis diseases so that the cognition of synovitis could be enhanced for clinical reference. Case presentation: The present study reported a 50-year-old female patient who suffered from intermittent left knee pain with limited movement for 9 years. The conditions were aggravated after long-term standing or walking and remitted after taking a rest, accompanied by noose and jamming. The specialist range of motion (ROM) examinations of the left knee revealed: 30° - 0° - 110° and left McMurray sign (+). Plain MRI scanning revealed that in the left knee cavity and the popliteal fossa area, a large number of low signals on free rice-like bodies were visible inside and the lower femur and the upper tibia exhibited abnormally high signals of patchy lipography. Surgical exploration revealed numerous rice-like free bodies in the suprapatellar bursa, the intercondylar fossa, and the posterior articular capsule. The patient presently has resolution of symptoms after surgical treatment. Conclusions: The RBS of the knee joint is very rare in the clinic. As MRI examination can provide valuable information, clinicians should actively perform MRI examination. Once the disease is diagnosed by examination, surgery is the optimal treatment.
... However, repeated local injections increase the tendency toward infection and crystallization, causing poor compliance [3]. Arthroscopic synovectomy can also relieve the symptoms temporarily, but patients usually relapse within half a year, sometimes even progressing to a more serious condition because of incomplete resection and the inability to reverse synovial pathology [4]. Therefore, a long-acting therapy administered locally to the joints is urgently needed in the clinic. ...
Article
Full-text available
Background Persistent synovial hyperplasia with inflammation in rheumatoid arthritis is one of the main pathogeneses of refractory rheumatoid arthritis (RRA). Photodynamic therapy (PDT) causes less trauma than steroid injections or arthroscopic synovectomy while providing stronger targeting and more durable curative effects. The aim of this trial was to evaluate the short-, medium-, and long-term clinical efficacy of PDT when applied as a treatment for RRA synovial hyperplasia and synovitis. Methods and analysis This protocol is for a single-center, randomized, double-blind, blank-controlled prospective trial. A sample of 126 RRA patients will be randomly divided into 3 groups: the control group, the “PDT once” group, and the “PDT twice” group, with 42 participants per group. The trial will be conducted by the Rheumatology and Immunology Department of the Integrated Hospital of Traditional Chinese Medicine, Southern Medical University. The Ultrasound Compound Score of Synovitis (UCSS) has been selected as the primary outcome measure. The secondary outcome measures include knee joint clinical assessments, ratio of relapse, duration of remission, Disease Activity Score in 28 joints (DAS28), inflammation indexes, serum concentrations of specific antibodies, and changes in articular structures as detected by X-ray scans in the 48th week. The improvement ratios of the UCSS at the 8th, 24th, and 48th weeks (compared with baseline) reflect short-, medium-, and long-term time frames, respectively. Ethics and dissemination The protocol was approved by the Medical Ethics Committee of the Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, China (Approval No. granted by the ethics committee: NFZXYEC-2017-005) and then entered in the Chinese Clinical Trials Registry under registration number ChiCTR1800014918 (approval date: February 21, 2018). All procedures are in accordance with Chinese laws and regulations and with the Declaration of Helsinki by the World Medical Association (WMA). Any modifications of this protocol during execution will need additional approval from the Ethics Committee of our hospital. Trial registration number ChiCTR1800014918.
... The continuous curative effect of long-term treatments is poor and can easily cause inflammation and crystallisation; furthermore, patient compliance is also poor [3]. Arthroscopic synovectomy shows some improvement over steroid injection, but it is a limited invasive treatment that can result in large injuries and cannot completely excise the synovium; additionally, it is unable to change the characteristics of the synovial pathology, and symptoms can recur in half a year or even sooner [4]. There remains a need for therapy with long-term efficacy for joint local treatment in the clinic. ...
Preprint
Full-text available
Background Persistent synovial hyperplasia with inflammation in rheumatoid arthritis is the main cause of refractory rheumatoid arthritis (RRA). As a means of local treatment, photodynamic therapy (PDT) confers less trauma, stronger targeting, and more durable curative effects than steroid injections or arthroscopic synovectomy. The aim of this trial will be to evaluate the short-, medium- and long-term clinical efficacy of PDT in the treatment of RRA synovial hyperplasia and synovitis. Methods and analysis This is a single-centre, randomised, double-blind, blank-controlled, prospective trial. A sample of 126 RRA patients will be randomly divided into 3 groups: the control group, the PDT once group, and the PDT twice group, 42 per group. The trial will be conducted at the Rheumatology and Immunology Department of Integrated Hospital of Traditional Chinese Medicine, Southern Medical University. Assessments at baseline, the first operation, the second operation (4th week), and then at three follow-ups (8th week, 24th week, 48th week) will be performed. The Ultrasound Compound Score of Synovitis (UCSS), knee joint clinical assessments, Disease Activity Score in 28 Joints (DAS28), serological inflammation indexes and specific antibody levels, pathological biopsies of synovial tissue and X-ray assessments of bone destruction will be evaluated. An improvement in the UCSS will be the main endpoint, and the UCSS at the 8th week versus the baseline value will reflect the short-term outcome of the operation. The results of the 24th week and 48th week follow-up will reflect the medium- and long-term curative effects, respectively. Ethics and dissemination The protocol was approved by the Medical Ethics Committee of Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, China (Approval No. of the ethics committee: NFZXYEC-2017-005) and later registered in the Chinese Clinical Trials Registry with Registration number ChiCTR1800014918 (approval date: February 21, 2018). All procedures will be in accordance with Chinese laws and regulations, as well as the WMA Declaration of Helsinki. Any modifications to the protocol will be approved by the Ethics Committee of our hospital. Trial registration number ChiCTR1800014918.
... Rheumatoid arthritis is characterized by swelling in the joints, tenderness on palpation, morning stiffness, decreased range of motion, and weakening in the muscles due to them [71][72][73]. Therefore, the presence of posture, atrophy, swelling, scar tissue, skin changes, and deformity should be observed with the inspection [74,75]. ...
Chapter
Full-text available
Rheumatoid arthritis is a progressive, chronic, and degenerative disease that adversely affects the quality of life of individuals. Depending on the individual’s symptoms of rheumatoid arthritis, basic and instrumental daily life activities are restricted, and participation of life is adversely affected. Occupational therapy interventions for rheumatoid arthritis rehabilitation include self‐management programs (e.g., arthritis self‐management program, bone up on arthritis, self‐management arthritis treatment physical activity), splinting techniques for rheumatoid arthritis, and vocational rehabilitation. In this chapter, updated information about these approaches is brought together and presented to the reader.
Article
Background: Surgical treatment can be considered for patients with undifferentiated arthritis (UA) limited to the elbow joint. The purpose of this study was to analyze the clinical outcomes of arthroscopic synovectomy. Methods: Nineteen patients who underwent arthroscopic synovectomy for chronic UA of the elbow between 2006 and 2019 were enrolled in this study. One patient was excluded because of evidence of tuberculosis in the biopsy. Chronic UA of the elbow was defined as (1) localized synovitis diagnosed by magnetic resonance imaging, (2) no specific cause, and (3) no response to conservative treatment for >3 months. We compared baseline characteristics and clinical outcomes between the remission and disease progression groups. Results: Postoperatively, synovitis was controlled in 13 patients. In 5 patients, the symptoms disappeared after surgery without any medical treatment. Four patients discontinued disease-modifying antirheumatic drugs. Nine patients were classified as in remission. The disease progression group had a longer symptom duration, elevated rheumatoid markers, and higher Larsen grading. However, the difference was not statistically significant. Conclusions: Arthroscopic synovectomy achieved remission in approximately 47% of patients with chronic UA of the elbow. Although arthroscopic synovectomy did not prevent RA, it can be considered for rapid resolution of synovitis and diagnostic purposes.
Article
Introduction: Arthritis is affecting millions of people globally, involvement and distribution depending on the type of arthritis. The most common arthritic conditions are osteoarthritis (OA) and Rheumatoid arthritis (RA). Despite the pathogeneses being fundamentally different, both joint diseases share the same need for local treatment of synovitis. Evidence acquisition: No current treatment can stop the progression of OA. Local articulate treatment including glucocorticoid (GC) injections, radiosynoviorthesis (RSO) and surgical synovectomy are the only options to relieve pain and temporally improve movability before surgical intervention. For RA, despite effective systemic treatments, similarly need for local articulate treatment is still present, especially early in the disease, but also in case of recurrent episodes of disease flare. Evidence synthesis: Current evidence supports local GC injection as first line treatment for persistent synovitis in a single or a few joints. RSO provides an evident and effective alternative for GC refractory synovitis, especially in early RA. Surgical synovectomy is an invasive alternative, but with less documented efficacy. Whether one unsuccessful intraarticular GC injection is enough to change of mode of action for local treatment is still unclear and needs to be further investigated. Conclusions: In conclusion persistent single joint synovitis in OA and RA is well treated with local treatment. Intra-articular GC injection is considered as first line of treatment, but RSO provides an additional treatment alternative with less side effects and better evidence of efficacy than surgical synovectomy.
Chapter
Inflammatory arthritis of elbow at the outset may present with pain, swelling, and restriction of movements, while deformities are associated with chronic cases. Surgical intervention is the mainstay of treatment, especially in rheumatoid elbow not responding to conservative management and disease-modifying anti-rheumatoid drug (DMARD) therapy. Traditionally, open procedures along with radial head resection were the most popular procedures and associated with severe morbidities as elbow joints are very notorious for being stiff after any manipulation or surgical intervention. With the advent of new techniques, equipment, and surgical skills, it is convenient to perform synovectomy, debridement, and decompression of elbow joint with keyhole arthroscopic surgeries, which are becoming very popular to improve arc of motion and pain relief with minimal postoperative morbidity as it allows early rehabilitation. Recent literature has documented effectiveness of arthroscopic synovectomy in inflammatory arthritis (mild-to-moderate severity) of elbow at short-term as well as long-term follow-up. Arthroscopic surgery of elbow is more demanding than open procedures so a steep learning curve may be expected for surgeons.
Article
Rheumatoid arthritis (RA) is a common chronic autoimmune disease that results from synovial hyperplasia. The hyperplasia of synovium directly degrades cartilage by secreting matrix-degrading enzymes and inducing cartilage degradation and even loss of joint function. In this study, a metal/semiconductor composite, octahedral copper sulfide shell, and gold nanorod core (Au [email protected]) is designed for, photothermal therapy (PTT), photodynamic therapy (PDT), and chemotherapy (CT) combination therapy for RA to remove hyperplasia of the synovium. Upon laser irradiation, the coupling of the local surface electromagnetic field improves the electromagnetic field of the Au NR core and the absorption of light of the CuS shell, whereby the photothermal effect is enhanced. Due to the Fenton-like reactions and the integration of Au NR and CuS semiconductor photocatalyst inhibits hole recombination and provides a reaction site for photocatalysis, which introduces additional •OH to photodynamics therapy. In addition, the large octahedral void space in Au [email protected] NPs can be used for loading a high quantity of drugs for chemotherapy, and modified with vasoactive intestinal peptide and hyaluronic acid (HA) formation VIP-HA-Au [email protected] NPs to target synovial cells in RA. Under combination therapy, VIP-HA-Au [email protected] NPs were shown to effectively inhibit the synovial cells and the edema degree of the CIA mouse was alleviated apparently. Both in vitro and in vivo studies indicate that the VIP-HA-Au [email protected] NPs can provide a potential possibility for the treatment of RA.
Article
Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease causing destruction of bone and cartilago articularis. Traditional treatment methods have many side effects, or too concerne about the anti-inflammatory mechanisms but ignore osteanagenesis. In this work, a novel therapeutic platform combined black phosphorus nanosheets (BPNs) into platelet-rich plasma (PRP)-chitosan thermoresponsive hydrogel has been prepared for management of RA. The BPNs generate local heat upon near-infrared irradiation, and delivering reactive oxygen species (ROS) to the inflamed joints simultaneously for removing hyperplastic synovial tissue. The injectable chitosan thermoresponsive hydrogel can take control of the releasing of BPNs degradation products, which provide ample raw materials for osteanagenesis. In addition, the PRP can effectively improve the adhesion and increase capacity of mesenchymal stem cells on chitosan thermosensitive hydrogels. And this thermoresponsive hydrogel can protect articular cartilage by reducing the friction on the surrounding tissue. Drug delayed release property was indicated by the release and uptake of methotrexate. The edema degree of the arthritic mouse was reduced obviously by the BPNs/Chitosan/PRP thermoresponsive hydrogel. Both in vitro and in vivo studies suggest that the thermoresponsive hydrogel can provide a potential possibility for the management of RA.
Article
Full-text available
To evaluate the treatment outcome of wrist and elbow arthroscopic synovectomy for patients with rheumatoid arthritis. 3 men and 18 women aged 27 to 71 (mean, 54) years underwent arthroscopic synovectomy for rheumatoid arthritis of the wrist (n=12) and elbow (n=13). All patients had received multiple medications including non-steroidal anti-inflammatory drugs, disease-modifying anti-rheumatic drugs, and steroids, as well as physiotherapy and splintage for 6 months, but the joint pain and disability persisted. The median duration of rheumatoid arthritis was 89 (range, 24-156) and 108 (range, 36-360) months for the wrist and elbow joints, respectively. According to the Larsen grading, the radiographic stages of the wrists and elbows were classified as grade 1 (n=4+4), grade 2 (n=4+5), and grade 3 (n=4+4). Visual analogue scale for pain, the wrist and elbow flexion-extension arcs, grip strength, key pinch strength, inflammatory markers, disability and symptoms were compared pre- and post-operatively. The median follow-up period was 30 (range, 18-78) and 34 (range, 18-78) months for wrists and elbows, respectively. There was significant improvement in pain, joint motion, inflammatory markers, and disability score. All patients were satisfied with the surgery. There was no neurovascular or wound complication. No patient was taking longterm pain-control drugs. One patient underwent a second arthroscopic synovectomy after 15 months owing to exacerbation of arthritis. Arthroscopic synovectomy is recommended for patients with rheumatoid arthritis who fail conservative treatment.
Article
The short-term assessment of 14 arthroscopic synovectomies of the elbow in 11 patients with rheumatoid arthritis showed that 93% achieved a short-term rating of excellent or good on the Mayo Elbow Performance Score. At the most recent assessment at an average of 42 months, however, only 57% maintained excellent or good results; four had required total elbow replacement. Although rehabilitation is facilitated by an arthroscopic procedure the results deteriorate more rapidly than after open synovectomy. This may be due to the limitations of the arthroscopic technique and is consistent with experience of the similar procedure in the knee. Recognition of the short-term gain and the potential for serious nerve injury should be considered when offering arthroscopic synovectomy.
Article
It is commonly known that rheumatoid arthritis involves the elbow joint with joint destructive change. However, the natural history of the elbow joint and surgical indications based on this course is not well recognized yet. The goals of the present study were to document the natural history of the elbow joint in patients who have rheumatoid arthritis and to determine the stage at which the natural progression should be interrupted by surgical treatment. Methods: We randomly reviewed the medical records and radiographs of the 296 (17.2%) elbow out of 1725 patients who have rheumatoid arthritis; we could follow the natural history of 28 elbows of 22 patients in a long clinical term. Twenty-eight elbows could be categorized into one of three groups: Group A, No radiological progression at elbow joint (50.0%); Group B, Chronic and slowly development (over 6 years) of elbow joint destruction (17.9%); Group C, Acute or subacute development (Grade 0 to Grade 4, 5 in Larsen classification during 3~6 years) (32.1%). Coronoid Height Ratio (CoHR) of the ulnar coronoid process and Curvature Radius (R) of the ulnar sigmoid notch were measured radiologically. Results: There were no significant differences of the Coronoid Height Ratio in groups A and B. Acute or subacute progression of joint destruction was seen in the elbow that had a CoHR of over 60%. These findings were most frequent in group C. There was no relationship of Curvature Radius of the ulnar sigmoid notch between groups A, B and C. The Coronoid Height Ratio could be classified as stage I (<50%), E (50~59%), and III (≧60%). The results indicated that natural history of the rheumatoid elbow could be classified into stage I which could be recognized as almost normal, stage II which has a high risk of progression, and stage IE which needs surgical treatment. Conclusions: Rheumatoid arthritis of the elbow joint commonly has the potential to progress rapidly, resulting in severe joint destruction. The Coronoid Height Ratio, one of the valuable parameters of the natural history, provides useful diagnostic information, particularly prognosis for progression of joint destruction. Through knowledge of the natural history is essential in the planning of appropriate and timely treatment to prevent progression of joint destruction and functional disturbance.
Article
Sixty-seven patients who have had surgical synovectomy of the digital joints of the hand for rheumatoid disease have been presented in this clinical study. Three hundred and ninety joints are represented. The results of synovectomy in these patients were evaluated according to six factors: relief of pain, progression of deformity, progression of roentgenographic changes, recurrence of synovial swelling, increase in range of motion, and gain in strength. When all six categories were considered collectively, 43.2 per cent of our patients had either excellent or good results. The relationship of the result of surgical synovectomy to the systemic disease state of the individual patients and to the disease state in the operated joint is emphasized.
Article
The purpose of this study was to evaluate the reoperation rate of elbow synovectomy in patients with rheumatoid arthritis. A total of 103 synovectomies were performed in 88 patients (6 1 women) with rheumatoid factor-positive rheumatoid arthritis with a mean follow-up of 5.2 years (range, 1-8 years). The survival rate after elbow synovectomy (free from reoperation) was 77% (95% confidence interval, 66%-85%) at 5 years. Eight resynovectomies and fourteen total elbow replacements were performed during the follow-up. No significant improvement in range of motion was detected after synovectomy, but pain relief and patient satisfaction were favorable. Elbows were classified preoperatively (before primary synovectomy) with the Larsen system. All resynovectomies were performed for elbows of grade 0-2 destruction. A significant difference was found between early (Larsen grade 0-2) and late (Larsen grade 3) synovectomies in relation to elbow replacement (P = .002) during the follow-up. Late synovectomy yielded more temporary pain relief with a high rate of elbow arthroplasties.
Article
Objective. The development and validation of Modified Disease Activity Scores (DAS) that include different 28-joint counts. Methods. These scores were developed by canonical discriminant analyses and validated for criterion, correlational, and construct validity. The influence of disease duration on the composition of the DAS was also investigated. Results. No influence of disease duration was found. The Modified DAS that included 28-joint counts were able to discriminate between high and low disease activity (as indicated by clinical decisions of rheumatologists). Conclusion. The Modified DAS are as valid as disease activity scores that include more comprehensive joint counts.